Found: 30
Select item for more details and to access through your institution.
Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases.
- Published in:
- Neuro-Oncology Practice, 2024, v. 11, n. 4, p. 395, doi. 10.1093/nop/npae001
- By:
- Publication type:
- Article
2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis.
- Published in:
- American Journal of Medical Genetics. Part A, 2018, v. 176, n. 5, p. 1258, doi. 10.1002/ajmg.a.38675
- By:
- Publication type:
- Article
Are Current Technical Exclusion Criteria for Clinical Trials of Magnetic Resonance–Guided High‐Intensity Focused Ultrasound Too Restrictive?: Early Experiences at a Pediatric Hospital.
- Published in:
- Journal of Ultrasound in Medicine, 2020, v. 39, n. 9, p. 1849, doi. 10.1002/jum.15259
- By:
- Publication type:
- Article
Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023).
- Published in:
- Sarcoma, 2020, p. 1, doi. 10.1155/2020/5784876
- By:
- Publication type:
- Article
Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016).
- Published in:
- Sarcoma, 2019, p. 1, doi. 10.1155/2019/7656747
- By:
- Publication type:
- Article
Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies.
- Published in:
- Sarcoma, 2017, p. 1, doi. 10.1155/2017/7429697
- By:
- Publication type:
- Article
The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 2, p. 524, doi. 10.1007/s10637-010-9585-1
- By:
- Publication type:
- Article
Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. 5, p. 707, doi. 10.1093/neuonc/nou004
- By:
- Publication type:
- Article
Current Treatment Options for Malignant Peripheral Nerve Sheath Tumors.
- Published in:
- Current Treatment Options in Oncology, 2015, v. 16, n. 3, p. 1, doi. 10.1007/s11864-015-0328-6
- By:
- Publication type:
- Article
Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 11, p. 1, doi. 10.1002/pbc.29282
- By:
- Publication type:
- Article
A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors.
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 4, p. 603, doi. 10.1002/pbc.25344
- By:
- Publication type:
- Article
Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 3, p. 396, doi. 10.1002/pbc.24281
- By:
- Publication type:
- Article
Preclincial testing of Sorafenib and RAD001 in the Nf<sup> flox/flox</sup> ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 58, n. 2, p. 173, doi. 10.1002/pbc.23015
- By:
- Publication type:
- Article
Preclincial testing of sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging.
- Published in:
- 2012
- By:
- Publication type:
- journal article
The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
- Published in:
- Pediatric Blood & Cancer, 2008, v. 51, n. 6, p. 768, doi. 10.1002/pbc.21741
- By:
- Publication type:
- Article
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G.
- Published in:
- Oncologist, 2024, v. 29, n. 8, p. 723, doi. 10.1093/oncolo/oyae119
- By:
- Publication type:
- Article
Outcome of Patients With Malignant Peripheral Nerve Sheath Tumors Enrolled on Sarcoma Alliance for Research Through Collaboration (SARC) Phase II Trials.
- Published in:
- Oncologist, 2023, v. 28, n. 5, p. 453, doi. 10.1093/oncolo/oyac272
- By:
- Publication type:
- Article
Sorafenib and Sunitinib.
- Published in:
- Oncologist, 2009, v. 14, n. 8, p. 800, doi. 10.1634/theoncologist.2009-0088
- By:
- Publication type:
- Article
Characteristics and Outcome of Pediatric Patients Enrolled in Phase I Oncology Trials.
- Published in:
- Oncologist, 2008, v. 13, n. 6, p. 679, doi. 10.1634/theoncologist.2008-0046
- By:
- Publication type:
- Article
Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 10, p. 1883, doi. 10.1093/neuonc/noad086
- By:
- Publication type:
- Article
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 1845, doi. 10.1093/neuonc/noac165
- By:
- Publication type:
- Article
Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 1978, doi. 10.1093/neuonc/noac109
- By:
- Publication type:
- Article
Development and pilot validation of a novel disfigurement severity scale for plexiform neurofibromas in children with neurofibromatosis type 1.
- Published in:
- Clinical Trials, 2024, v. 21, n. 2, p. 189, doi. 10.1177/17407745231206402
- By:
- Publication type:
- Article
Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials.
- Published in:
- Clinical Trials, 2024, v. 21, n. 1, p. 40, doi. 10.1177/17407745231203330
- By:
- Publication type:
- Article
Boiling histotripsy lesion characterization on a clinical magnetic resonance imaging-guided high intensity focused ultrasound system.
- Published in:
- PLoS ONE, 2017, v. 12, n. 3, p. 1, doi. 10.1371/journal.pone.0173867
- By:
- Publication type:
- Article
Rhabdomyosarcoma of Head and Neck in Children.
- Published in:
- Otolaryngology-Head & Neck Surgery, 2012, v. 145, n. 2, p. P236, doi. 10.1177/0194599812451426a354
- By:
- Publication type:
- Article